What antibiotics are recommended for an adult with chronic bronchitis?

Antibiotics Are NOT Recommended for Stable Chronic Bronchitis

For adults with stable chronic bronchitis, routine antibiotic use is not recommended, as there is insufficient evidence that antibiotics relieve cough or improve outcomes in the absence of an acute exacerbation. 1

Key Distinction: Stable vs. Acute Exacerbation

The critical decision point is whether the patient has stable chronic bronchitis or an acute exacerbation of chronic bronchitis (AECB):

Stable Chronic Bronchitis (No Antibiotics)

• The 2020 CHEST guidelines explicitly state there is insufficient evidence to recommend routine use of antibiotics for stable chronic bronchitis as a means of relieving cough. 1
• Prophylactic antibiotics have been studied and do not reduce the number of exacerbations, though they may reduce days lost from work. 2
• The most effective intervention is smoking cessation and avoidance of respiratory irritants (environmental pollutants, occupational exposures). 1

Acute Exacerbation (Antibiotics May Be Indicated)

Antibiotics should be reserved for patients meeting BOTH criteria:

1. At least ONE cardinal symptom:

   • Increased dyspnea
   • Increased sputum volume
   • Increased sputum purulence 3, 4

2. At least ONE risk factor:

   • Age ≥65 years
   • FEV1 <50% predicted
   • ≥4 exacerbations in past 12 months
   • Presence of comorbidities 3

Antibiotic Selection for AECB (When Indicated)

Moderate Severity Exacerbations:

• Newer macrolides (azithromycin, clarithromycin)
• Extended-spectrum cephalosporins
• Doxycycline 3

Severe Exacerbations:

• High-dose amoxicillin/clavulanate
• Respiratory fluoroquinolones (levofloxacin, moxifloxacin) 3, 5

Common pitfall: Avoid using amoxicillin alone, erythromycin, or trimethoprim-sulfamethoxazole due to increasing bacterial resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 2

Patients at Risk for Pseudomonas aeruginosa:

• Consider anti-pseudomonal fluoroquinolones or other agents with appropriate coverage. 4

Alternative Management for Stable Disease

Since antibiotics are not indicated for stable chronic bronchitis, focus on:

• Bronchodilators: Short-acting β-agonists, ipratropium bromide, or combined long-acting β-agonist with inhaled corticosteroids may improve cough. 1
• Smoking cessation: The single most effective intervention. 1
• Avoidance of irritants: Workplace hazards, passive smoke, environmental pollutants. 1
• NOT recommended: Expectorants, postural drainage, chest physiotherapy have no proven benefit. 1

Duration of Antibiotic Therapy (When Used for AECB)

• Fluoroquinolones can be effective with 5-day courses and may achieve greater bacterial load reduction than β-lactams or macrolides, potentially prolonging time between exacerbations. 6
• Standard courses are typically 5-10 days depending on severity and agent selected. 3

Critical caveat: The presence of bacteria in sputum during stable periods does not indicate need for antibiotics, as colonization is common and does not predict benefit from antimicrobial therapy. 2, 4